Gene Therapy: It Is Time to Talk about High-Dose AAV

Abstract

Get full access to this article

View all access options for this article.

References

https://www.joshuafrase.org/get-involved/recensus-study.php.

Search of: AAV | Interventional Studies—List Results—ClinicalTrials.gov.

Search of: AAV8 | Interventional Studies—List Results—ClinicalTrials.gov.

Mendell

, Al-Zaidi

, Shell

, et al. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N. Engl. J. Med. , 2017; 377: 1713–1722.

https://www.prnewswire.com/news-releases/audentes-announces-positive-interim-data-from-first-dose-cohort-of-aspiro-a-phase-12-clinical-trial-of-at132-in-patients-with-x-linked-myotubular-myopathy-300577455.html.

https://www.solidbio.com/about/media/news/letter-to-the-duchenne-community-about-the-status-of-the-ignite-dmd-clinical-trial.

https://www.fiercebiotech.com/biotech/solid-bio-sees-yet-another-clinical-hold-for-its-dmd-gene-therapy.

https://investors.pfizer.com/investor-news/press-release-details/2020/Pfizers-New-Phase-1b-Results-of-Gene-Therapy-in-Ambulatory-Boys-with-Duchenne-Muscular-Dystrophy-DMD-Support-Advancement-into-Pivotal-Phase-3-Study/default.aspx.

Wilson

, Flotte

. Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy. Hum. Gene Ther. , 2020; 31(13–14): 695–696.

10.

Flotte

. Revisiting the “New” Inflammatory Toxicities of Adeno-Associated Virus Vectors. Hum. Gene Ther. , 2020; 31: 398–399.

11.

Rumachik

, Malaker

, Poweleit

, et al. Methods Matter: Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct Vectors. Mol. Ther. Methods Clin. Dev. , 2020; 18: 98–118.

12.

Davidoff

, Ng

CYC

, Zhou

, Spence

, Nathwani

. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood , 2003; 102: 480–488.